Zhou; Juan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhou; Juan.The latest application filed is for "formation method for liquid rubber composite nodes with tubular flow channel".

Company Profile

10.7.16

Zhou; Juan - Ann Arbor MI
ZHOU; Juan - Hunan CN
ZHOU; Juan - Wuxi CN
ZHOU; Juan - Shanghai CN
Zhou; Juan - Zhejiang CN
ZHOU; Juan - Shenzhen CN
ZHOU; Juan - Hangzhou Zhejiang
ZHOU; Juan - Heze CN
Zhou; Juan - Jiangsu CN
Zhou; Juan - Zhuhai City CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Fibroblast growth factor receptor 2-specific peptide reagents and methods Grant 11,406,720 - Wang , et al. August 9, 2	2022-08-09
Formation Method For Liquid Rubber Composite Nodes With Tubular Flow Channel App 20220196102 - LUO; Jun ; et al.	2022-06-23
Detection Of Colonic Neoplasia In Vivo Using Near-infrared Peptide Targeted Against Overexpressed Cmet App 20220193271 - Wang; Thomas D. ; et al.	2022-06-23
Fusion Albumin Nanoparticle and Application Thereof App 20220073590 - CHEN; Jinghua ; et al.	2022-03-10
Glypican-3 peptide reagents and methods Grant 11,248,022 - Zhou , et al. February 15, 2	2022-02-15
An Additive Composition And Application Thereof App 20200369809 - WEI; Zhen ; et al.	2020-11-26
Five-membered heterocyclic amides WNT pathway inhibitor Grant 10,821,104 - Wang , et al. November 3, 2	2020-11-03
Benzofuran pyrazole amine kinase inhibitor Grant 10,710,993 - Wang , et al.	2020-07-14
Fibroblast Growth Factor Receptor 2-Specific Peptide Reagents and Methods App 20200138979 - Wang; Thomas D. ; et al.	2020-05-07
Peptide Reagents And Methods For Detection And Targeting Of Dysplasia, Early Cancer And Cancer App 20200102349 - Wang; Thomas D. ; et al.	2020-04-02
Glypican-3 Peptide Reagents and Methods App 20200010508 - Zhou; Juan ; et al.	2020-01-09
Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer Grant 10,500,290 - Wang , et al. Dec	2019-12-10
Gamma Compensation Circuit And Display Device App 20190333466 - ZHOU; Juan ; et al.	2019-10-31
Benzofuran Pyrazole Amine Kinase Inhibitor App 20190225600 - WANG; Yonghui ; et al.	2019-07-25
High-quality, Lithium-rich And Manganese-based Positive Electrode Material For Lithium Ion Battery, And Method For Synthesizing Same App 20190115595 - DONG; Xin ; et al.	2019-04-18
Self-interference channel estimation method and device Grant 10,153,921 - Zhou , et al. Dec	2018-12-11
Five-membered Heterocyclic Amides Wnt Pathway Inhibitor App 20180271846 - WANG; Yonghui ; et al.	2018-09-27
Modulation policy for modular multi-level converter Grant 9,787,219 - Wu , et al. October 10, 2	2017-10-10
Peptide Reagents And Methods For Detection And Targeting Of Dysplasia, Early Cancer And Cancer App 20170246324 - Wang; Thomas D. ; et al.	2017-08-31
Self-interference Channel Estimation Method And Device App 20170141937 - ZHOU; Juan ; et al.	2017-05-18
Modulation Policy For Modular Multi-level Converter App 20150171771 - Wu; Xiaojie ; et al.	2015-06-18
Window-blind App 20140116630 - Zhou; Juan	2014-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.